Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06671730 · ClinicalTrials.gov registry record · NA
Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer
A NA study of Breast Cancer Survivor, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT06671730: Recruiting NA study of Breast Cancer Survivor, sponsored by University of Oklahoma.
NCT06671730 is a NA study of Breast Cancer Survivor that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 38 participants, below the 98-participant average among 5 other Breast Cancer Survivor trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06671730, a NA study of Breast Cancer Survivor, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
We will evaluate a novel 8-week telehealth-delivered occupational therapy (OT) program among breast cancer survivors that seeks to promote engagement in aerobic physical activity (PA) and muscle strengthening exercise (MSE). The telehealth-based delivery of this OT program circumvents some barriers to OT access and participation (e.g., time burden; distance to OT clinic) among breast cancer survivors- particularly important for Oklahoma given that 33% of residents live in rural areas. Additionally, the focus of this program is to promote the preferred aerobic PA and MSE choices of each individual survivor to increase the likelihood of long-term PA engagement. In turn, participants will be more likely to experience the longer-term benefits associated with PA such as improved physical functioning, reduced anxiety, depressive, and pain symptoms, better sleep, and better cardiorespiratory fitness.
Primary Outcome
Semi-structured Interviews and face valid questionnaires will be used to determine whether BC survivors found the intervention acceptable. The semi-structured interviews will be evaluated via thematic analysis, and the questionnaires will be scored on a 7-point Likert scale (1: 'Not at all'; 7: 'Very'), with higher scores being better.
Conditions Studied
Interventions
- BEHAVIORAL 8-Week Telehealth-based Occupational Therapy Program
Study Locations (1)
Oklahoma
- University of Oklahoma Health Sciences - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2024-11-27 |
| Est. Completion | 2025-10-17 |
| Phase | NA |
What NCT06671730 shows while recruiting
NCT06671730 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 98-participant average among 5 other Breast Cancer Survivor trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Breast Cancer Survivor appearing as the primary indexed condition, and to 1 intervention - of which 8-Week Telehealth-based Occupational Therapy Program is the first listed.
NCT06671730 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06671730 about?
NCT06671730 is a clinical study titled "Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer". We will evaluate a novel 8-week telehealth-delivered occupational therapy (OT) program among breast cancer survivors that seeks to promote engagement in aerobic physical activity (PA) and muscle strengthening exercise (MSE). The telehealth-based delivery of this OT program circumvents some barriers ...
What is the current status of trial NCT06671730?
This trial is currently recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2024-11-27. Estimated completion is 2025-10-17.
What conditions does trial NCT06671730 study?
This clinical trial studies the following conditions: Breast Cancer Survivor.
What interventions are being tested in trial NCT06671730?
The interventions under investigation include: 8-Week Telehealth-based Occupational Therapy Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06671730?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06671730 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Survivor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors
RECRUITING · NA
-
Group Interventions for Breast Cancer Survivors
ACTIVE NOT RECRUITING · NA
-
Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors
ACTIVE NOT RECRUITING · NA
-
mHealth for Breast Cancer Survivors With Insomnia
COMPLETED · NA
-
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI